This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia.
Here are medtech stories we missed this week but thought were still worth mentioning:
1. Corindus touts first Asian use of next-generation robot
Corindus Vascular Robotics announced in a March 31 press release that robot-assisted PCI procedures were performed for the first time in Asia using the CorPath GRX system. The procedures were performed at Fu Wai Hospital. This is the first time the system has been used outside of the U.S. CorPath GRX enhances the precision and workflow of the current CorPath system and extends the capabilities and procedures that can be robot-assisted.
2. Endologix launches stent graft study
Endologix has announced that the first patients of its Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study have been treated, according to a March 31 press release. The purpose of the clinical trial is to test the efficiency and safety of the Ovation alto abdominal stent graft system that repairs infrarenal abdominal aortic aneurysms. The clinical trials will have 75 participants across 12 centers in the U.S.
3. NeoSurgical inks Europe distribution deal for Neoclose
NeoSurgical announced in a March 29 press release that it has signed a distribution deal with a global partner to commercialize the Neoclose in Europe. Neoclose helps surgeons close port site defects up to 3 cm after laparoscopic abdominal surgery. It uses bioabsorbable anchors and a Vector-X closure to help change port site closure.